Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luciana Marinelli

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Seminars in Cancer Biology|August 29, 2017
Probiotic species in the modulation of the anticancer immune responseLuciana Marinelli, Gian Carlo Tenore, Ettore Novellino
Journal of Medicinal Chemistry|March 6, 2007
Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculationsSandro Cosconati, Luciana Marinelli, Antonio Lavecchia, et al.
Chem|April 7, 2025
Minute-timescale free-energy calculations reveal a pseudo-active state in the adenosine A<sub>2A</sub> receptor activation mechanismVincenzo Maria D'Amore, Paolo Conflitti, Luciana Marinelli, et al.
Current Topics in Medicinal Chemistry|December 30, 2011
From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affairBarbara Cosimelli, Sandro Cosconati, Luciana Marinelli, et al.
Scientific Reports|January 21, 2014
Beyond radio-displacement techniques for identification of CB1 ligands: the first application of a fluorescence-quenching assayAgostino Bruno, Francesca Lembo, Ettore Novellino, et al.
Journal of Medicinal Chemistry|August 6, 2004
Human integrin alphavbeta5: homology modeling and ligand bindingLuciana Marinelli, Kay-E Gottschalk, Axel Meyer, et al.
Journal of Medicinal Chemistry|October 3, 2003
Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug designLuciana Marinelli, Antonio Lavecchia, Kay-E Gottschalk, et al.
Gastroenterology|June 14, 2022
A Small CEACAM5 Peptide Restores the Protective Function of CD8<sup>+</sup> Regulatory T Cells in Crohn's DiseaseDavid Dunkin, Francesco Merlino, Carmen Correale, et al.
Angewandte Chemie (International Ed. in English)|March 31, 2007
Probing integrin selectivity: rational design of highly active and selective ligands for the alpha5beta1 and alphavbeta3 integrin receptorDominik Heckmann, Axel Meyer, Luciana Marinelli, et al.
Journal of Medicinal Chemistry|June 25, 2005
Ligand binding analysis for human alpha5beta1 integrin: strategies for designing new alpha5beta1 integrin antagonistsLuciana Marinelli, Axel Meyer, Dominik Heckmann, et al.
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Seminars in Cancer Biology|August 29, 2017
Probiotic species in the modulation of the anticancer immune responseLuciana Marinelli, Gian Carlo Tenore, Ettore Novellino
Journal of Medicinal Chemistry|March 6, 2007
Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculationsSandro Cosconati, Luciana Marinelli, Antonio Lavecchia, et al.
Chem|April 7, 2025
Minute-timescale free-energy calculations reveal a pseudo-active state in the adenosine A<sub>2A</sub> receptor activation mechanismVincenzo Maria D'Amore, Paolo Conflitti, Luciana Marinelli, et al.
Current Topics in Medicinal Chemistry|December 30, 2011
From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affairBarbara Cosimelli, Sandro Cosconati, Luciana Marinelli, et al.
Scientific Reports|January 21, 2014
Beyond radio-displacement techniques for identification of CB1 ligands: the first application of a fluorescence-quenching assayAgostino Bruno, Francesca Lembo, Ettore Novellino, et al.
Journal of Medicinal Chemistry|August 6, 2004
Human integrin alphavbeta5: homology modeling and ligand bindingLuciana Marinelli, Kay-E Gottschalk, Axel Meyer, et al.
Journal of Medicinal Chemistry|October 3, 2003
Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug designLuciana Marinelli, Antonio Lavecchia, Kay-E Gottschalk, et al.
Gastroenterology|June 14, 2022
A Small CEACAM5 Peptide Restores the Protective Function of CD8<sup>+</sup> Regulatory T Cells in Crohn's DiseaseDavid Dunkin, Francesco Merlino, Carmen Correale, et al.
Angewandte Chemie (International Ed. in English)|March 31, 2007
Probing integrin selectivity: rational design of highly active and selective ligands for the alpha5beta1 and alphavbeta3 integrin receptorDominik Heckmann, Axel Meyer, Luciana Marinelli, et al.
Journal of Medicinal Chemistry|June 25, 2005
Ligand binding analysis for human alpha5beta1 integrin: strategies for designing new alpha5beta1 integrin antagonistsLuciana Marinelli, Axel Meyer, Dominik Heckmann, et al.
Pageof 16